Grenoble: In laboratories from the Alps to the Baltic, scientists have spent months squinting at a single number. The Commission’s proposed FP10 budget, the successor to the Horizon Europe research programme, would command roughly 175 billion euros over 2028 to 2034, close to double the sum backing today’s scheme and a rare pledge of growth in a strained Union budget.

The figure sits inside the wider battle over the bloc’s next seven-year financial framework, and researchers know from experience that headline promises can shrink once member states start trimming. Still, the ambition marks a deliberate signal that Europe intends to spend its way toward technological relevance rather than watch talent and patents drift to the United States and China.

The proposed programme keeps a familiar architecture of pillars spanning fundamental science, industrial competitiveness and breakthrough innovation, while binding itself more tightly to a new European Competitiveness Fund. That linkage has unsettled parts of the research community, who fear that curiosity-driven inquiry could be squeezed by a heavier emphasis on market-ready applications and strategic autonomy.

Governments are already jockeying over control. Ministers agreed a partial negotiating position in June that demands a greater say in shaping priorities, a move universities read as capitals reaching for the steering wheel. Advocacy groups counter that excellence, not political direction, should decide where grants land, and that a firewall around basic science must survive the horse-trading.

Smaller members and newer entrants press a different grievance. They complain that the lion’s share of funding flows to a handful of research-heavy countries, and they want the next programme to widen participation so that laboratories in the east and south are not perennially outbid. Balancing that fairness against a ruthless pursuit of the best proposals will test the negotiators.

Industry lobbies, meanwhile, want speed and simplicity. They argue that byzantine application rules deter exactly the nimble start-ups the bloc says it craves, and they urge deep cuts to paperwork alongside the fatter cheque. Analysts tracking the file, including specialist outlets covering the FP10 proposal, expect the haggling to run well into next year.

For the scientists refreshing their inboxes, the practical questions are simpler. Will the money survive the budget wars intact, will the rules let them chase bold ideas without drowning in forms, and will a laboratory far from the wealthy core stand a fair chance. On the answers rests much of Europe’s hope of staying at the frontier of discovery.